Reconstruction of a pathway of antigen processing and class II MHC peptide capture

EMBO Journal

Volumn 26, Issue 8, 2007, Pages 2137-2147

  Moss, Catherine X ^a,c   Tree, Timothy I ^b   Watts, Colin ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Antigen processing; B cell antigen receptor (BCR); Class II MHC

Indexed keywords

AUTOANTIGEN; B LYMPHOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEINASE; TETANUS TOXIN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; CELL LINE; CHROMATOGRAPHY, GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICROSCOPY, FLUORESCENCE; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, ANTIGEN, B-CELL; TETANUS TOXIN;

EID: 34247235534     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7601660     Document Type: Article

References (52)

1. Antoniou AN, Blackwood SL, Mazzeo D, Watts C (2000) Control of antigen presentation by a single protease cleavage site. Immunity 12: 391-398
2. Arndt SO, Vogt AB, Markovic-Plese S, Martin R, Moldenhauer G, Wolpl A, Sun Y, Schadendorf D, Hammerling GJ, Kropshofer H (2000) Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J 19: 1241-1251
3. Astill TP, Ellis RJ, Arif S, Tree TI, Peakman M (2003) Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules. Diabetologia 46: 496-503
4. Berzofsky JA (1983) T-B reciprocity. An Ia-restricted epitope-specific circuit regulating Tcell-B cell interaction and antibody specificity. Surv Immunol Res 2: 223-229
5. Castellino F, Zappacosta F, Coligan JE, Germain RN (1998) Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol 161: 4048-4057
6. Chien Jr PC, Cohen S, Tuen M, Arthos J, Chen PD, Patel S, Hioe CE (2004) Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing. J Virol 78: 7645-7652
7. Dai Y, Carayanniotis KA, Eliades P, Lymberi P, Shepherd P, Kong Y, Carayanniotis G (1999) Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J Immunol 162: 6987-6992
8. Davidson HW, Reid PA, Lanzavecchia A, Watts C (1991) Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 67: 105-116
9. Davidson HW, Watts C (1989) Epitope-directed processing of specific antigen by B lymphocytes. J Cell Biol 109: 85-92
10. Davidson HW, West MA, Watts C (1990) Endocytosis, intracellular trafficking, and processing of membrane IgG and monovalent antigen/membrane IgG complexes in B lymphocytes. J Immunol 144: 4101-4109
11. Delamarre L, Couture R, Mellman I, Trombetta ES (2006) Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J Exp Med 203: 2049-2055
12. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES (2005) Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307: 1630-1634
13. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82: 155-165
14. Engelhard VH (1994) Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 12: 181-207
15. Groothuis TAM, Neefjes J (2005) The ins and outs of intracellular peptides and antigen presentation by class I MHC molecules. Curr Top Microbiol Immunol 300: 127-148
16. Guermonprez P, Lo-Man R, Sedlik C, Rojas MJ, Poljak RJ, Leclerc C (1999) mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells. Int Immunol 11: 1863-1872
17. Hewitt EW, Treumann A, Morrice N, Tatnell PJ, Kay J, Watts C (1997) Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation. J Immunol 159: 4693-4699
18. Jaume JC, Parry SL, Madec AM, Sonderstrup G, Baekkeskov S (2002) Suppressive effect of glutamic acid decarboxylase 65-specific autoimmune B lymphocytes on processing of T cell determinants located within the antibody epitope. J Immunol 169: 665-672
19. Kloetzel P (2004) Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. Nat Immunol 5: 661-669
20. Knight AM, Lucocq JM, Prescott AR, Ponnambalam S, Watts C (1997) Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Igα/Igβ dimer. EMBO J 16: 3842-3850
21. Lanzavecchia A (1985) Antigen-specific interaction between Tand B cells. Nature 314: 537-539
22. Lanzavecchia A (1990) Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 8: 773-793
23. Lee P, Matsueda GR, Allen PM (1988) T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing. J Immunol 140: 1063-1068
24. Li D, Matthews SP, Antoniou AN, Mazzeo D, Watts C (2003) Multistep autoactivation of asparaginyl endopeptidase in vivo and in vitro. J Biol Chem 278: 38980-38990
25. Lindner R, Unanue ER (1996) Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J 15: 6910-6920
26. Lippolis JD, White FM, Marto JA, Luckey CJ, Bullock TN, Shabanowitz J, Hunt DF, Engelhard VH (2002) Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol 169: 5089-5097
27. Loak K, Li DN, Manoury B, Billson J, Morton F, Hewitt E, Watts C (2003) Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase. Biol Chem 384: 1239-1246
28. Malcherek G, Gnau V, Jung G, Rammensee HG, Melms A (1995) Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J Exp Med 181: 527-536
29. Manca F, Kunkl A, Fenoglio D, Fowler A, Sercarz E, Celada F (1985) Constraints in T-B cooperation related to epitope topology on E. coli b-galactosidase I. The fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants. Eur J Immunol 15: 345-350
30. Manoury B, Hewitt EW, Morrice N, Dando PM, Barrett AJ, Watts C (1998) An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation [see comments]. Nature 396: 695-699
31. Manoury B, Mazzeo D, Fugger L, Viner N, Ponsford M, Streeter H, Mazza G, Wraith DC, Watts C (2002) Destructive processing by asparagine endopeptidase limits presentation of a dominant Tcell epitope in MBP. Nat Immunol 3: 169-174
32. Moss CX, Villadangos JA, Watts C (2005) Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. Eur J Immunol 35: 3442-3451
33. Nelson CA, Vidavsky I, Viner NJ, Gross ML, Unanue ER (1997) Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 94: 628-633
34. Pamer E, Cresswell P (1998) Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16: 323-358
35. Quaratino S, Ruf J, Osman M, Guo J, McLachlan S, Rapoport B, Londei M (2005) Human autoantibodies modulate the T cell epitope repertoire but fail to unmask a pathogenic cryptic epitope. J Immunol 174: 557-563
36. Rhodin NR, Van Tilburg ML, Oli MW, McArthur WP, Brady L J (2004) Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1. Infect Immun 72: 13-21
37. Rock KL, York IA, Goldberg AL (2004) Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat Immunol 5: 670-677
38. Russell HI, York IA, Rock KL, Monaco JJ (1999) Class II antigen processing defects in two H2d mouse cell lines are caused by point mutations in the H2-DMa gene. Eur J Immunol 29: 905-911
39. Santambrogio L, Sato AK, Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ (1999) Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci USA 96: 15056-15061
40. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, Moura IC, Lennon-Dumenil AM, Seabra MC, Raposo G, Amigorena S (2006) NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218
41. Sercarz EE, Maverakis E (2003) MHC-guided processing: binding of large antigen fragments. Nat Rev Immunol 3: 621-629
42. Sette A, Adorini L, Colon SM, Buus S, Grey HM (1989) Capacity of intact proteins to bind to MHC class II molecules. J Immunol 143: 1265-1267
43. Shastri N, Schwab S, Serwold T (2002) PRODUCING NATURE'S GENE-CHIPS: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 20: 463-493
44. Shimonkevitz R, Kappler J, Marrack P, Grey H (1983) Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med 158: 303-316
45. Shirai M, Arichi T, Chen M, Nishioka M, Ikeda K, Takahashi H, Enomoto N, Saito T, Major ME, Nakazawa T, Akatsuka T, Feinstone SM, Berzofsky JA (1999) T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region. J Immunol 162: 568-576
46. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C (1995) Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants [see comments]. J Exp Med 181: 1957-1963
47. Villadangos JA, Driessen C, Shi G-P, Chapman HA, Ploegh HL (2000) Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM. EMBO J 19: 882-891
48. Watts C (2001) Antigen processing in the endocytic compartment. Curr Opin Immunol 13: 26-31
49. Watts C (2004) The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 5: 685-692
50. Watts C, Antoniou A, Manoury B, Hewitt EW, McKay LM, Grayson L, Fairweather NF, Emsley P, Isaacs N, Simitsek PD (1998) Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen. Immunol Rev 164: 11-16
51. Watts C, Lanzavecchia A (1993) Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 178: 1459-1463
52. Watts C, West MA, Reid PA, Davidson HW (1989) Processing of immunoglobulin-associated antigen in B lymphocytes. Cold Spring Harb Symp Quant Biol 1: 345-352